This URM Pre-doctoral research fellowship is a competitive, non-renewable, merit-based award intended to enhance research and/or clinical training of promising students who are matriculated in pre-doctoral or clinical health professional degree training programs and who intend careers as scientists, physician-scientists or other clinician-scientists aimed at continuing ataxia basic science, translational science or clinical research towards the goal of serving individuals with ataxia.
This award provides partial support for study and research and may be used to support pre-doctoral students who are pursuing research with an ataxia-relevant theme. Proposals across the spectrum of basic, translational, and clinical research are welcome.
LOI Deadline
August 15, 2025 by 11:59 PM Eastern Time
To utilize the proposalCENTRAL online portal to submit letters of intent and applications, a user account
needs to be created. Use this weblink https://proposalcentral.com to create an account. Creating an
account can be done any time prior to submitting a Letter of Intent (LOI) to apply.
Application Deadline
December 5, 2025 by 11:59 PM Eastern Time
Application is not available until LOI has been approved.
Funding Information
This award provides up to two years of support, beginning April 1, 2026 to March 31, 2028, totaling $50,000 ($25,000 per year).
Funding can be used to support direct research costs associated with the funded proposal and can be used to support the fellow’s annual stipend.
Indirect costs and cost sharing are prohibited from being applied to NAF grants.
A progress report is required 11 months after the start of the grant funding term. The second year of funding is contingent on demonstration of progress by the awardee.
NAF retains the right to unilaterally cancel any awards for non-compliance or non-performance
At the time of application, the applicant must:
1. Have a baccalaureate degree or equivalent and be currently enrolled in a PhD or equivalent research degree program (e.g., PharmD, PsyD, ScD), a formally combined MD/PhD program, or other combined professional/clinical and research doctoral (e.g., DDS/PhD) in the U.S.
2. Have successfully completed their qualifying exams, or equivalent*, in their respective programs by the final grant due date.
3. Be a U.S. citizen, non-citizen U.S. national, U.S. permanent residents, individual granted deferred action status under the Deferred Action for Childhood Arrivals Program, or individual granted Temporary Protected Status.
4. Identify as one or more of the following:
i. An individual from underrepresented racial and ethnic groups in the U.S., including but not limited to Black or African American, Hispanic or Latino, American Indian or Alaska Native, Native Hawaiian and other Pacific Islanders. Individuals from racial or ethnic groups not listed here that can be demonstrated convincingly to be underrepresented by the grantee institution are also encouraged to apply.
ii. An individual who identifies as LGBTQIA+.
iii. Individuals with a disability, who are defined as those with a physical or mental impairment that substantially limits one or more major life activities, as described in the Americans with Disabilities Act of 1990.
5. Have identified a research project and sponsor, show evidence of high academic performance in the sciences, and a commitment to a career as an independent research scientist, or as an independent physician-scientist or other clinician-scientist (dual-degree training) with a specialized interest in ataxias. The primary sponsor should be an active investigator and be committed both to the candidate’s research training and to direct supervision of his/her/their research.
6. Applicants are only eligible to submit one application per year. Applicants should select the grant program that best suits their current position and proposal.
Eligible Countries:
Sponsor Institute/Organizations: National Ataxia Foundation
Sponsor Type: Corporate/Non-Profit
Address: 600 Highway 169 South, Suite 1725 Minneapolis, MN 55426
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Aug 15, 2025
Dec 05, 2025
$25,000
Affiliation: National Ataxia Foundation
Address: 600 Highway 169 South, Suite 1725 Minneapolis, MN 55426
Website URL: https://www.ataxia.org/researcher-resources/#spnResearchGrants
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.